Enzalutamide Impurity 29

Product Description
CAT No.
ALN-E015047
CAS No.
NA
Mol. F.
C28H20F5N5O3S
Mol. Wt.
601.6
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-(3-fluoro-4-(methylcarbamoyl)phenyl)benzamide
Smiles : O=C(NC1=CC=C(C(NC)=O)C(F)=C1)C2=CC=C(N(C(N3C4=CC=C(C#N)C(C(F)(F)F)=C4)=S)C(C)(C)C3=O)C=C2F
Inchi : InChI=1S/C18H10F6N4O/c1-28(13-5-3-11(9-26)15(7-13)18(22,23)24)16(29)27-12-4-2-10(8-25)14(6-12)17(19,20)21/h2-7H,1H3,(H,27,29)
Technical Data
Reference
Structural elucidation of the impurities in Enzalutamide bulk drug and the development, validation of corresponding HPLC method
Xingling Mab , Wentao Zhoua , Qiaogen Zoua,*, Pingkai OuyangnJournal of Pharmaceutical and Biomedical Analysis Volume 131, 30 November 2016, Pages 436-443
Crystal Forms of Enzalutamide and a Crystal Engineering Route to Drug Purification
, Pingkai Ouyang – Journal of Pharmaceutical and Biomedical Analysis Volume 131, 30 November 2016, Pages 436-443
Quantitative Study of\xa0Impurities in\xa0Enzalutamide and\xa0Identification, Isolation, Characterization of\xa0Its Four Degradation Products Using HPLC, Semi-preparative LC, LC/ESI–MS and\xa0NMR Analyses
Lucia Maini, Dario Braga, Francesco Farinella, Elisa Melotto, Massimo Verzini, Roberto Brescello, Ivan Michieletto, and Ilaria Munari – Cryst. Growth Des. 2018, 18, 7, 3774–3780
RFQ